These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1628428)
1. Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response. Scheeren RA; Oostendorp RA; van der Baan S; Keehnen RM; Scheper RJ; Meijer CJ Clin Exp Immunol; 1992 Jul; 89(1):94-9. PubMed ID: 1628428 [TBL] [Abstract][Full Text] [Related]
2. Defects in cellular immunity in chronic upper airway infections are associated with immunosuppressive retroviral p15E-like proteins. Scheeren RA; Keehnen RM; Meijer CJ; van der Baan S Arch Otolaryngol Head Neck Surg; 1993 Apr; 119(4):439-43. PubMed ID: 8457306 [TBL] [Abstract][Full Text] [Related]
3. Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer. Simons PJ; Oostendorp RA; Tas MP; Drexhage HA Cancer Immunol Immunother; 1994 Mar; 38(3):178-84. PubMed ID: 8124686 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of retroviral-P15E-related material in carcinomas of the head and neck. Tan IB; Drexhage HA; Mullink R; Hensen-Logmans S; De Haan-Meulman M; Snow GB; Balm AJ Otolaryngol Head Neck Surg; 1987 Mar; 96(3):251-5. PubMed ID: 3108807 [TBL] [Abstract][Full Text] [Related]
5. In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients. Kerrebijn JD; Simons PJ; Tas M; Balm AJ; Drexhage HA Eur Arch Otorhinolaryngol; 1995; 252(7):409-16. PubMed ID: 8562036 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive retroviral P15E-related factors in head and neck carcinomas. Tan IB; Drexhage HA; Scheper RJ; von Blomberg-van de Flier BM; de Haan-Meulman M; Snow GB; Balm FJ Arch Otolaryngol Head Neck Surg; 1986 Sep; 112(9):942-5. PubMed ID: 3741659 [TBL] [Abstract][Full Text] [Related]
7. The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours. Stöger H; Wilders-Truschnig M; Samonigg H; Schmid M; Bauernhofer T; Tiran A; Tas M; Drexhage HA Clin Exp Immunol; 1993 Sep; 93(3):437-41. PubMed ID: 8370172 [TBL] [Abstract][Full Text] [Related]
8. Retroviral p15E-related serum factors and recurrence of head and neck cancer. Tas MP; Laarman D; Haan-Meulman MD; Balm AJ; Snow GB; Drexhage HA Clin Otolaryngol Allied Sci; 1993 Aug; 18(4):324-8. PubMed ID: 8877195 [TBL] [Abstract][Full Text] [Related]
9. Effects of tumor growth on host defenses. Cianciolo GJ; Snyderman R Cancer Metastasis Rev; 1986; 5(1):15-27. PubMed ID: 3524888 [TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory proteins associated with human and murine neoplasms. Cianciolo GJ Biochim Biophys Acta; 1986 Aug; 865(1):69-82. PubMed ID: 3524686 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer. Tan IB; Balm AJ; Snow GB; Drexhage HA Eur Arch Otorhinolaryngol; 1990; 247(6):387-90. PubMed ID: 2278707 [TBL] [Abstract][Full Text] [Related]
12. Effect of P15E related retroviral material isolated from head and neck carcinomas on delayed type hypersensitivity skin reactions in mice. Tan IB; Drexhage HA; Scheper RJ; von Blomberg-van de Flier BM; dP6Haan-Meulman M; Snow GB; Balm FJ Laryngoscope; 1987 Jun; 97(6):710-2. PubMed ID: 3586812 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth. Lang MS; Hovenkamp E; Savelkoul HF; Knegt P; Van Ewijk W Clin Exp Immunol; 1995 Dec; 102(3):468-75. PubMed ID: 8536359 [TBL] [Abstract][Full Text] [Related]
14. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E. Cianciolo GJ; Lostrom ME; Tam M; Snyderman R J Exp Med; 1983 Sep; 158(3):885-900. PubMed ID: 6193238 [TBL] [Abstract][Full Text] [Related]
15. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E. Lang MS; Oostendorp RA; Simons PJ; Boersma W; Knegt P; van Ewijk W Cancer Res; 1994 Apr; 54(7):1831-6. PubMed ID: 7511054 [TBL] [Abstract][Full Text] [Related]
16. Macrophage and dendritic cell infiltration in head and neck squamous-cell carcinoma; an immunohistochemical study. Kerrebijn JD; Balm AJ; Knegt PP; Meeuwis CA; Drexhage HA Cancer Immunol Immunother; 1994 Jan; 38(1):31-7. PubMed ID: 8299116 [TBL] [Abstract][Full Text] [Related]
17. Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum. van de Plassche-Boers EM; Tas M; de Haan-Meulman M; Kleingeld M; Drexhage HA Clin Exp Immunol; 1988 Sep; 73(3):348-54. PubMed ID: 3264768 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-mediated immunomodulation: hydrocortisone enhances immunosuppressive endogenous retroviral protein (p15E) expression in mouse immune cells. Fiegl M; Strasser-Wozak E; Geley S; Gsur A; Drach J; Kofler R Clin Exp Immunol; 1995 Aug; 101(2):259-64. PubMed ID: 7648710 [TBL] [Abstract][Full Text] [Related]
19. Retroviral protein P15E and tumorigenesis. Expression is neither required nor sufficient for tumor development. Schmidt DM; Snyderman R J Immunol; 1988 Jun; 140(11):4035-41. PubMed ID: 3372996 [TBL] [Abstract][Full Text] [Related]
20. Expression of a suppressive p15E-related epitope in colorectal and gastric cancer. Foulds S; Wakefield CH; Giles M; Gillespie J; Dye JF; Guillou PJ Br J Cancer; 1993 Sep; 68(3):610-6. PubMed ID: 7688979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]